Alpelisib for PIK3CA-Mutated Advanced Breast Cancer. Reply.

N Engl J Med

Novartis Pharmaceuticals, East Hanover, NJ.

Published: August 2019

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1907856DOI Listing

Publication Analysis

Top Keywords

alpelisib pik3ca-mutated
4
pik3ca-mutated advanced
4
advanced breast
4
breast cancer
4
cancer reply
4
alpelisib
1
advanced
1
breast
1
cancer
1
reply
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!